Health Trials

Immunologic Suppression

2

Review clinical trials related to Immunologic Suppression. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Immune Homeostasis in Sepsis and Septic Shock

Detailed description of immune response and its dynamics in sepsis and septic shock patiens by means of transcriptomics, flow-cytometry and cytokine analysis.

Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Charles University, Czech RepublicUpdated: Aug 21, 2024Locations: 1Duration: 90 Days
Eligibility criteria

sepsis/septic shock (SEPSIS-3) [+3]

disagreement of the patient or legal representative with the entry into the stud... [+2]

Read more
Status: Recruiting

Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies

This study aims to evaluate the clinical efficacy of cyclophosphamide in patients receiving a bone marrow graft from a matched unrelated donor in overall survival, progression free survival and cumulative incidence of acute and chronic GvHD. Thirty patients will receive cyclophosphamide while twenty patients will receive antihuman T-lymphocyte immune globulin (ATG).

Participants needed: 50
Trial details
Phase: Phase 2, Phase 3Age: 1-75Biological sex: AllType: InterventionalSponsor: Hospital Israelita Albert EinsteinUpdated: Feb 1, 2019Locations: 1
Eligibility criteria

Men and Women of Any Age [+3]

Acute leukemias not in complete response (that is > 5% blast in the bone marrow) [+6]

Read more